Correction: TP53, CDKN2A/P16, and NFE2L2/NRF2 regulate the incidence of pure- and combined-small cell lung cancer in mice (Oncogene, (2022), 41, 25, (3423-3432), 10.1038/s41388-022-02348-0)

Samera H. Hamad, Stephanie A. Montgomery, Jeremy M. Simon, Brittany M. Bowman, Kyle B. Spainhower, Ryan M. Murphy, Erik S. Knudsen, Suzanne E. Fenton, Scott H. Randell, Jeremiah R. Holt, D. Neil Hayes, Agnieszka K. Witkiewicz, Trudy G. Oliver, M. Ben Major, Bernard E. Weissman

Research output: Contribution to journal › Comment/debate

Fingerprint

Dive into the research topics of 'Correction: TP53, CDKN2A/P16, and NFE2L2/NRF2 regulate the incidence of pure- and combined-small cell lung cancer in mice (Oncogene, (2022), 41, 25, (3423-3432), 10.1038/s41388-022-02348-0)'. Together they form a unique fingerprint.

Medicine & Life Sciences